Skip to main content
. 2021 Jan 18;7:609889. doi: 10.3389/fvets.2020.609889

Table 2.

Survival probability calculated with Kaplan-Meier estimators (in days) and compared with the log rank test.

Treatment
Variable Log rank test CG HG PCG SG THG
Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI Mean ± SD 95% CI
Symmetry Index 0.000* 28.6 ± 7.5 13.9–43.2 111.8 ± 20.5 71.5–152.1 171.0 ± 9.5 152.3–189.7 80.3 ± 19.6 43.7–116.9 94.5 ± 16.8 78.8–115.7
Deviation 0.031* 48.8 ± 16.6 16.3–81.3 130.5 ± 22.3 86.8–174.2 147.0 ± 18.6 110.5–183.5 90.8 ± 23.9 43.8–137.8 99.0 ± 23.7 52.5–145.5
HVAS 0.012* 49.7 ± 17.5 15.4–84.0 117.0 ± 18.7 80.3–153.7 144.0 ± 17.3 110.2–177.8 129.8 ± 18.9 92.7–166.9 66.1 ± 20.1 26.7–105.5
PSS 0.485 63.2 ± 24.3 15.6–110.8 142.5 ± 16.9 109.4–175.7 150.0 ± 14.3 122.1–177.9 94.6 ± 23.2 49.2–140.0 90.2 ± 24.9 41.4–139.0
PIS 0.000* 8.7 ± 0.7 7.3–10.1 114.0 ± 22.7 69.6–158.4 138.0 ± 15.8 106.9–169.1 109.6 ± 25.6 59.4–159.8 118.6 ± 23.0 76.5–119.0
LOAD 0.000* 40.7 ± 16.3 10.6–70.8 141.8 ± 16.3 109.8–173.8 120.0 ± 18.7 83.3–156.6 123.8 ± 20.1 84.5–163.1 124.3 ± 22.5 80.2–129.4
Stiffness 0.592 64.7 ± 24.0 17.7–111.7 129.8 ± 20.5 89.7–169.9 141.0 ± 15.7 110.1–171.9 111.8 ± 22.5 67.7–155.9 130.8 ± 16.4 98.7–162.9
Function 0.013* 65.4 ± 18.9 28.4-102.4 168.0 ± 10.0 148.3–187.7 135.0 ± 13.8 107.9–162.0 124.5 ± 21.8 81.7–167.3 112.6 ± 22.1 69.3–155.9
Gait 0.328 52.7 ± 20.7 12.1–93.3 115.5 ± 18.5 79.2–151.8 123.0 ± 18.3 87.2–158.8 103.6 ± 26.2 60.0–147.2 117.0 ± 22.2 73.5–160.5
QOL 0.533 60.9 ± 21.3 19.2–102.6 120.0 ± 17.5 85.7–154.3 120.8 ± 19.2 83.1–158.5 66.2 ± 25.7 15.9–116.5 119.3 ± 25.8 68.8–169.8
COI 0.380 52.7 ± 18.9 15.7–89.7 93.1 ± 23.6 46.8–139.4 138.0 ± 15.7 107.2–168.8 78.1 ± 19.8 39.3–116.9 78.9 ± 22.5 34.8–123.0

CG, Control group; COI, Canine Orthopedic Index; HG, Hylan G-F 20 group; HVAS, Hudson Visual Analog Scale; LOAD, Liverpool Osteoarthritis in Dogs; OFA, Orthopedic Foundation for Animals; PCG, Platelet Concentrate group; PIS, Pain Interference Score; PSS, Pain Severity Score; QOL, Quality of Life; SG, Stanozolol group; THG, Triamcinolone hexacetonide group.

*

indicates significance.